/
Erasca, Inc.
Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
Mentions
1 mention · latest on 10 Jul 2026
See which tracked investors hold Erasca, Inc. →Ownership and position changes on OwnershipTrace
| Value Hive PodcastPodcast | Seedy19: A 35x Return From Biotech Investing | - | 10 Jul 2026 |